Can't find Octreotide? Here are FDA-approved alternatives like Lanreotide, Pasireotide, and other options your doctor may consider.
If your pharmacy just told you Octreotide is out of stock — or if you've been searching for days with no luck — it's natural to feel anxious. Octreotide isn't a medication you can just skip. Whether you take it for acromegaly, carcinoid syndrome, or neuroendocrine tumors, missing doses can lead to real problems.
The good news: there are alternatives. Other medications in the same class can treat many of the same conditions, and your doctor can help you find the right one. In this article, we'll cover what Octreotide does, how it works, and the best alternatives to discuss with your healthcare team.
Octreotide is a synthetic version of somatostatin, a hormone your body naturally produces to regulate other hormones and certain body functions. As a somatostatin analog, Octreotide mimics somatostatin but is much more potent and lasts longer in the body.
Octreotide is FDA-approved to treat:
It's also widely used off-label for gastroenteropancreatic neuroendocrine tumors, esophageal variceal bleeding, hepatorenal syndrome, and other conditions. For a complete overview, read What Is Octreotide? Uses, Dosage, and What You Need to Know.
Octreotide works by binding to somatostatin receptors (especially subtypes 2 and 5) on cells throughout the body. When it attaches to these receptors, it:
Understanding how Octreotide works helps explain why certain alternatives may be good substitutes — they target the same receptors and produce similar effects. For a deeper dive, see our article on how Octreotide works.
The following medications are the most commonly used alternatives. Always talk to your doctor before switching medications — the right alternative depends on your specific condition, how you've responded to Octreotide, and your overall health.
Lanreotide is the most direct alternative to Octreotide. It's another somatostatin analog that targets the same receptors and is FDA-approved for:
How it's given: Deep subcutaneous injection every 4 weeks. Unlike Octreotide LAR (which requires intramuscular injection), Lanreotide comes in a prefilled syringe that can be self-administered or given by a caregiver after training.
Key differences from Octreotide:
Cost: Somatuline Depot costs approximately $5,500-$8,000 per monthly injection at cash price. Insurance typically covers it with prior authorization.
Pasireotide is a second-generation somatostatin analog that binds to a broader range of somatostatin receptors (SSTR1, 2, 3, and 5). This broader binding profile means it may be effective in patients who haven't responded well to Octreotide or Lanreotide.
FDA-approved for:
How it's given: Available as both a subcutaneous injection (twice daily) and a long-acting intramuscular injection (once monthly).
Important consideration: Pasireotide has a significantly higher risk of hyperglycemia (high blood sugar) than Octreotide. Patients switching to Pasireotide need close blood sugar monitoring, and diabetic patients may require medication adjustments.
Cost: Signifor LAR can cost $10,000-$15,000 per monthly injection, making it one of the more expensive options.
Pegvisomant works differently from somatostatin analogs. Instead of suppressing growth hormone release, it blocks the growth hormone receptor so that growth hormone can't exert its effects. This makes it a useful option for acromegaly patients who don't respond to somatostatin analogs.
FDA-approved for:
How it's given: Daily subcutaneous injection.
Key differences:
Cost: Somavert costs approximately $8,000-$14,000 per month depending on dosage.
Telotristat Ethyl is not a somatostatin analog — it works by inhibiting tryptophan hydroxylase, the enzyme that makes serotonin. This makes it useful specifically for carcinoid syndrome diarrhea.
FDA-approved for:
How it's given: Oral tablet, taken three times daily with food.
Key points:
Cost: Approximately $9,000-$12,000 per month.
The best alternative depends on your condition:
Your doctor may also consider trying a different formulation of Octreotide before switching drugs entirely. For example, if Sandostatin LAR is unavailable, generic immediate-release Octreotide injection may be available from manufacturers like Avet, Fresenius Kabi, or Hikma.
Not being able to fill your Octreotide prescription is stressful, but you have real options. Start by checking Medfinder to see if Octreotide is available at nearby pharmacies. If it's truly unavailable, talk to your doctor about switching to Lanreotide, Pasireotide, or another alternative that fits your condition.
For more information, explore our related guides:
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
